Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is...
Mar 17, 2026, 8:30 AM EDT - 19 days ago
Feb 24, 2026, 4:15 PM EST - 5 weeks ago
Feb 19, 2026, 8:30 AM EST - 6 weeks ago
Feb 4, 2026, 8:33 AM EST - 2 months ago
Jan 29, 2026, 8:33 AM EST - 2 months ago
Jan 20, 2026, 8:33 AM EST - 2 months ago
Jan 6, 2026, 8:21 AM EST - 3 months ago
Dec 18, 2025, 8:35 AM EST - 3 months ago
Dec 5, 2025, 4:10 PM EST - 4 months ago
Dec 3, 2025, 7:23 PM EST - 4 months ago
Mar 11, 2025, 9:16 AM EDT - 1 year ago
Mar 11, 2025, 6:09 AM EDT - 1 year ago